Orexigen Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Orexigen Therapeutics's estimated annual revenue is currently $12.3M per year.(i)
  • Orexigen Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Orexigen Therapeutics has 61 Employees.(i)
  • Orexigen Therapeutics grew their employee count by -3% last year.

Orexigen Therapeutics's People

NameTitleEmail/Phone
1
VP Supply Chain & Site HeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Orexigen Therapeutics?

Orexigen's commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Orexigen offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.

keywords:N/A

N/A

Total Funding

61

Number of Employees

$12.3M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Orexigen Therapeutics News

2022-04-17 - Weight Loss Therapeutics Market Is Booming So Rapidly | Top ...

Leading Manufacturers Analysis in Global Weight Loss Therapeutics Market 2022: ? Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen...

2022-03-30 - Global Obesity Treatment Market Research Report to 2027 ...

Orexigen Therapeutics, Inc. Pfizer, Inc; Sarl COUSIN BIOTECH; Technogym SpA; USGI Medical, Inc. Vivus, Inc. For more information about this...

2022-03-30 - Global Pharma, Biotech & Diagnostics Co-promotion and Co ...

Case study 3: Takeda Pharmaceutical- Orexigen Therapeutics. 3.4.1.b. Case study 4: Celgene - Acceleron Pharma.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.4M613%$62M
#2
$5.8M63-7%N/A
#3
$11.6M6317%N/A
#4
$17.5M6340%N/A
#5
$8.6M66-11%N/A